The purpose of this study was to investigate the effect and selectivity of an extract of Schisandra chinensis berries against Chlamydia pneumoniae and C. trachomatis. Among the ethnopharmacological uses of the extract from Schisandrae fructus are cough and pneumonia. Therefore we focused on respiratory pathogens. The extract completely inhibited the growth of C. pneumoniae strain CV6 at 250 μg/mL concentration. The inhibition of C. pneumoniae and C. trachomatis growth was dose dependent and established with three different strains. The extract inhibited C. pneumoniae production of infectious progeny in a dose dependent manner. Chlamydia selectivity was elucidated with growth inhibition measurements of three other respiratory bacterial species. A pure compound found in Schisandra chinensis berries, schisandrin B at 20.0 μg/mL concentration inhibited the growth of both C. pneumoniae and C. trachomatis. The extract was found to be non-toxic to the human host cells. These findings highlight the potential of the extract from Schisandra chinensis berries as a source for antichlamydial compounds.
YangZ, LinQ. (2005) Comparative morphology of the leaf epidermis in Schisandra (Schisandraceae). Botanical Journal of the Linnean Society, 148, 39–56.
2.
LuY, ChenD. (2009) Analysis of Schisandra chinensis and Schisandra sphenanthera. Journal of Chromatography A, 1216, 1980–1990.
3.
OpletalL, SovováH, BártlováM. (2004) Dibenzocyclooctadiene lignans of the genus Schisandra: importance, isolation and determination. Journal of Chromatography B, 812, 357–371.
4.
GuoLY, HungTM, BaeKH, ShinEM, ZhouHY, HongYN, KangSS, KimHP, KimYS. (2008) Anti-inflammatory effects of schisandrin isolated from the fruit of Schisandra chinensis Baill. European Journal of Pharmacology, 591, 293–299;
5.
StacchiottiA, VoltiGL, LavazzaA, RezzaniR, RodellaLF. (2009) Schisandrin B stimulates a cytoprotective response in rat liver exposed to mercuric chloride. Food and Chemical Toxicology, 47, 2834–2840;
6.
LeeTH, JungCH, LeeDH. (2012) Neuroprotective effects of schisandrin B against transient focal cerebral ischemia in Sprague-Dawley rats. Food and Chemical Toxicology, 50, 4239–4245.
7.
Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China. 1 (2010) China Medical Science Press.
8.
PavlushchenkoE. (1981) Pneumonia in aged and old people in conditions of the monsoon climate of the southern Primorskij region. New Data on Eleutherococcus and other Adaptogens, Far East Branch of the USSR Academy of Science, Institute of Marine Biology, Vladivostok, 119–122.
9.
PanossianA, WikmanG. (2008) Pharmacology of Schisandra chinensis Baill.: An overview of Russian research and uses in medicine. Journal of Ethnopharmacology, 118, 183–212.
10.
ChenD, ZhangS, XieL, XieJ, ChenK, KashiwadaY, ZhouB, WangP, CosentinoLM, LeeK. (1997) Anti-aids agents—XXVI. Structure-activity correlations of Gomisin-G-related anti-HIV lignans from Kadsura interior and of related synthetic analogues. Bioorganic Medicinal Chemistry, 5, 1715–1723;
11.
ChenM, KilgoreN, LeeK, ChenDF. (2006) Rubrisandrins A and B, lignans and related anti-HIV compounds from Schisandra rubriflora. Journal of Natural Products, 69, 1697–1701;
12.
YangGY, LiYK, WangRR, LiX, XiaoWL, YangLM, PuJX, ZhengYT, SunHD. (2010) Dibenzocyclooctadiene lignans from Schisandra wilsoniana and their anti-HIV-1 activities. Journal of Natural Products, 73, 915–919.
13.
SongQY, ZhangCJ, LiY, WenJ, ZhaoXW, LiuZL, GaoK. (2013) Lignans from the fruit of Schisandra sphenanthera, and their inhibition of HSV-2 and adenovirus. Phytochemistry Letters, 6, 174–178.
14.
ChenDF, ZhangSX, KozukaM, SunQZ, FengJ, WangQ, MukainakaT, NobukuniY, TokudaH, NishinoH. (2002) Interiotherins C and D, two new lignans from Kadsura interior and antitumor-promoting effects of related neolignans on Epstein-Barr virus activation. Journal of Natural Products, 65, 1242–1245.
15.
HanskiL, VuorelaPM. (2014) Recent advances in technologies for developing drugs against Chlamydia pneumoniae. Expert Opinion on Drug Discovery, 1–12;
16.
HahnDL, AzenaborAA, BeattyWL, ByrneGI. (2002) Chlamydia pneumoniae as a respiratory pathogen. Frontiers of Bioscience, 7, 66–76.
17.
GérardHC, SchumacherHR, El-GabalawyH, Goldbach-ManskyR, HudsonAP. (2000) Chlamydia pneumoniae present in the human synovium are viable and metabolically active. Microbial Pathogenesis, 29, 17–24;
18.
ZhanP, SuoL, QianQ, ShenX, QiuLX, YuL, SongY. (2011) Chlamydia pneumoniae infection and lung cancer risk: A meta-analysis. European Journal of Cancer, 47, 742–747;
19.
RoulisE, PolkinghorneA, TimmsP. (2013) Chlamydia pneumoniae: modern insights into an ancient pathogen. Trends in Microbiology, 21, 120–128.
20.
EkmanM, GraystonJT, VisakorpiR, KleemolaM, KuoC, SaikkuP. (1993) An epidemic of infections due to Chlamydia pneumoniae in military conscripts. Clinical Infectious Diseases, 17, 420–425;
21.
BlasiF, TarsiaP. (2005) Value of short-course antimicrobial therapy in community-acquired pneumonia. International Journal of Antimicrobial Agents, 26, S148–S155;
22.
HammerschlagMR, KohlhoffSA. (2012) Treatment of chlamydial infections. Expert Opinion in Pharmacotherapy, 13, 545–552.
23.
HuangX, SongF, LiuZ, LiuS. (2007) Studies on lignan constituents from Schisandra chinensis (Turcz.) Baill. fruits using high-performance liquid chromatography/electrospray ionization multiple-stage tandem mass spectrometry. Journal of Mass Spectrometry, 42, 1148–1161.
24.
IpSP, CheCT, KongYC, KoKM. (2001) Effects of schisandrin B pretreatment on tumor necrosis factor-α induced apoptosis and Hsp70 expression in mouse liver. Cell Stress Chaperones, 6, 44–48.
25.
European Pharmacopoeia (7th ed.) (2010) Vol. 1. Strasbourg: Council of Europe.
26.
AlvesaloJ, VuorelaH, TammelaP, LeinonenM, SaikkuP, VuorelaP. (2006) Inhibitory effect of dietary phenolic compounds on Chlamydia pneumoniae in cell cultures. Biochemical Pharmacology, 71, 735–741.
27.
KuoC, GraystonJT. (1990) A sensitive cell line, HL cells, for isolation and propagation of Chlamydia pneumoniae strain TWAR. Journal of Infectious Diseases, 162, 755–758.
28.
SandbergM, MäättänenA, PeltonenJ, VuorelaPM, FallareroA. (2008) Automating a 96-well microtitre plate model for Staphylococcus aureus biofilms: an approach to screening of natural antimicrobial compounds. International Journal of Antimicrobial Agents, 32, 233–240.
